Context Therapeutics Enters $75M At-The-Market Offering Agreement, Allocating Proceeds To R&D, Working Capital, And Potential Asset Acquisitions
Context Therapeutics Enters $75M At-The-Market Offering Agreement, Allocating Proceeds To R&D, Working Capital, And Potential Asset Acquisitions
Context Therapeutics進入7500萬美元的市場融資協議，分配收益用於研發、營運資金以及潛在資產收購
Context Therapeutics Enters $75M At-The-Market Offering Agreement, Allocating Proceeds To R&D, Working Capital, And Potential Asset Acquisitions
Context Therapeutics進入7500萬美元的市場融資協議，分配收益用於研發、營運資金以及潛在資產收購
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。